Peking Union Medical College Hospital: rheumatology, endocrinology and specialist expertise

What kind of hospital is PUMCH?

PUMCH’s official introduction identifies it as a tertiary Grade A comprehensive hospital with clinical care, research and medical education roles. For a second-opinion enquiry, that broad setting is a useful starting point for finding the specialty closest to an existing diagnosis.

This profile concentrates on two areas with identifiable expert and research information: rheumatology and endocrinology. It is not an exhaustive account of the hospital’s specialties.

Sources: [1]

Rheumatology: a referral practice and a research network

The hospital’s January 2023 department account describes care for lupus, Sjögren’s syndrome, rheumatoid arthritis, ankylosing spondylitis and complicated or rare rheumatic disorders. It reported over 120,000 outpatient visits annually at that time, alongside collective expert discussions for difficult cases.

That dated volume illustrates the scale of the department’s practice. Its involvement in multicentre research adds a second kind of evidence: experience is being organized into studies that other clinicians can examine. Visit counts do not, by themselves, establish a particular doctor’s outcomes.

Sources: [2]

Zhang Wen (张文): IgG4-related disease and complex rheumatology

Zhang Wen’s official clinical profile lists IgG4-related disease, lupus, Sjögren’s syndrome, rheumatoid arthritis, vasculitis and several uncommon conditions. That disease-specific information is more useful for matching a review question than a general senior title.

A February 2024 PUMCH research account identifies Zhang Wen and Fei Yunyun’s team with a multicentre randomized maintenance-treatment study in IgG4-related disease published in Annals of the Rheumatic Diseases. This is a concrete research contribution relevant to her documented clinical focus; it is not advice to change an individual patient’s medication.

Sources: [3], [4]

Xia Weibo (夏维波): endocrine and metabolic bone disease

The official profile describes Xia Weibo’s work in endocrine and metabolic disorders, with a particular focus on metabolic bone disease. It also records a University of Tokyo visiting-scholar period in 2000–2001. That is a documented training experience, not a claim of Japanese medical licensure.

His academic profile describes osteoporosis, fracture epidemiology and inherited bone-disorder research. The 2023 interpretation of China’s 2022 primary osteoporosis guideline lists Xia as corresponding author with a PUMCH Endocrinology affiliation. These provide identifiable examples of clinical focus and professional contribution.

Sources: [5], [6], [7]

Why these strengths matter when choosing a second opinion

A patient reviewing an established autoimmune diagnosis can look for a rheumatologist whose published clinical interests match the condition. An endocrine or bone-disease question calls for a different specialist. The benefit of a focused profile is that it makes those distinctions visible before an enquiry.

For the actual review, ask who will examine the records, which materials are needed and what written opinion will be produced. Department scale and publications support background research; the reviewing provider decides whether it can accept the case.

International patient information and the next step

PUMCH publishes an international department with more than 30 outpatient specialties and an English telephone option. This establishes an international patient-service route, not availability of a remote written review from every named expert.

Our initial enquiry needs the area of care, the existing diagnosis or decision to be reviewed, your country of residence and contact details. Do not put medical attachments in the initial form. We then check suitable specialist options and the written service scope.

Sources: [8]

Continue reading

• China hospital profiles: specialties, named experts and evidence you can check
• Zhongshan Hospital in Shanghai: liver cancer, cardiology and named experts
• Sun Yat-sen University Cancer Center: gastrointestinal cancer, nasopharyngeal cancer and specialist evidence